P186D

Claim your 0.75hr CE/CME Credit Here
Name*

First NameLast Name
Email*
example@example.com
What best describes your title?*

MD/DORN/NPPAPharmD/RPhRespiratory TherapistNon-Clinician Research CoordinatorOther
If MD/DO

cardiologist (interventional)cardiologist (heart failure)cardiologist (lipid/vascular)cardiologist (general)endocrinologistnephrologistemergency medicine specialistcritical care specialistpulmonologistprimary care providerindustryOther
If RN/NP

NPPICUcath labwardclinicacademicindustryOther
If PharmD

hospital/health system-basedcommunityacademicindustryOther
If PharmD, DOB

MonthDayYear
Date
If PharmD, NABP ID#
Where are you based?

EU/GBCanadaUSALatin AmericaAustralia/NZAsia
How did you FIRST hear about our tweetorials?

found it on Twitter searching in subject areafound it on twitter searching for CE/CMEfound it on Twitter by following individual influencerfound it on Twitter by following institutional influencerfrom LinkedIn
How many years have you been in practice?
How many patients per month do you typically see with the disease addressed in this tweetorial?
1. What would your initial treatment strategy be for a newly diagnosed high-risk PAH patient without comorbidities?*

a. Oral PDE5i onlyb. Oral ERA onlyc. Parenteral prostacyclin, PDE5i and ERAd. A&B
Patient description: 33y/o M in ED c/o dyspnea x 6 months. HIV+ and amphetamine user. BP on the low side, loud S2, parasternal heave. BNP and LFTs elevated. Each shows marked RV dilation and TR. RHC shows RA 12, RV 65/7, EDP 19, PA 61/21 with mean 39, PAWP 12, CO 2.43, CI 1.28, SVI 12, PVR 11 Wood units. MvO2 44%. There is no response to inhaled nitric oxide iNO. CT shows no parenchymal lung disease. Diagnosis of PAH made.
2. What is his PAH risk?*

a. Lowb. Intermediate-lowc. Intermediate-highd. High
3. Did you follow the entire tweetorial?*

YesNo
4. Did you find this to be an effective learning tool?*

YesNo
5. On a scale of 1 to 5, how applicable to your clinical practice was the material in this tweetorial?*

1

2

3

4

5

1 is Not At All Pertinent, 5 is Extremely Pertinent
6. How will this program change your practice?*

Not pertinent to my practiceReinforces my practiceMakes me want additional educationWill change my practice
7. Will you recommend @cardiomet_CE and/or this website to your colleagues?*

YesNo
MonthDayYear
Date
Course Title
Should be Empty: